BREMNER CAPITAL MANAGEMENT October 2014 Tekmira Pharmaceuticals Conference Calls 12/09/14 Participants: Tekmira: Julie Rezler (IR), Mark Murray (CEO) and Bruce Cousins (CFO) Bremner: Sam Kelly, Tancredi Marchiolo Ebola update: • The objective of the managem

a its pipeline of product candidates in development to treat serious human diseases such as cancer and viral infections like Hepatitis B and Ebola. Tekmira is advancing the development of novel drugs in areas where there is a significant unmet medical need and commercial opportunity and it also licences